Innate immune activation in neurodegenerative disease
The DOI matches its Crossref record; 171 of the 171 references it cites were found in a registry or an index.
Abstract
The triggering of innate immune mechanisms is emerging as a crucial component of major neurodegenerative diseases. Microglia and other cell types in the brain can be activated in response to misfolded proteins or aberrantly localized nucleic acids. This diverts microglia from their physiological and beneficial functions, and leads to their sustained release of pro-inflammatory mediators. In this Review, we discuss how the activation of innate immune signalling pathways - in particular, the NOD-, LRR- and pyrin domain-containing 3 (NLRP3) inflammasome - by aberrant host proteins may be a common step in the development of diverse neurodegenerative disorders. During chronic activation of microglia, the sustained exposure of neurons to pro-inflammatory mediators can cause neuronal dysfunction and contribute to cell death. As chronic neuroinflammation is observed at relatively early stages of neurodegenerative disease, targeting the mechanisms that drive this process may be useful for diagnostic and therapeutic purposes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There is corollary evidence for inflammation in FTD (Heneka et al., 2014), from genetic (Guerreiro et al., 2013; Rayaprolu et al., 2013; Broce et al., 2018), CSF (Sjogren et al., 2004; Woollacott et al., 2018), epidemiology (Miller et al., 2013, 2016), post-mortem (Venneti et al., 2008; Lant et al., 2014) and animal studies (Yoshiyama et al., 2007; Bhaskar et al., 2010; Yin et al., 2010).”
From Neuroinflammation and protein aggregation co-localize across the frontotemporal dementia spectrum (2020) · cites this paper as Heneka et al., 2014
In the citing paper
“in AD, the chronic release of DAMPs, mitochondrial-released DAMPs and pro-inflammatory molecules contributes to the onset and progression of neurodegeneration [57, 76, 97, 149, 194, 270, 304, 333, 345]”
From Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function (2022) · cites this paper as [149]
In the citing paper
“This is thought to divert microglia from performing house-keeping functions, promoting a low-grade inflammatory state and CNS damage [149, 333]”
From Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function (2022) · cites this paper as [149]
In the citing paper
“studies have shown that cellular aging, infection, traumatic brain injury, systemic inflammation, chronic inflammatory diseases, obesity and poor oral health occurring during middle adulthood can lead to increased pro-inflammatory signals in the periphery, which may contribute to glial activation and the onset and/or perpetuation of neurodegeneration [93, 105, 149, 333]”
From Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function (2022) · cites this paper as [149]
In the citing paper
“TLRs and associated signaling pathways contribute to both injurious and regenerative processes in CNS diseases (33–35).”
From UNC93B1 Is Widely Expressed in the Murine CNS and Is Required for Neuroinflammation and Neuronal Injury Induced by MicroRNA let-7b (2021) · cites this paper as [33]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Fate Mapping Analysis Reveals That Adult Microglia Derive from Primitive Macrophages
Ginhoux, F., Greter, M., Leboeuf, M., Nandi, S., See, P., Gokhan, S., Mehler, M. F., Conway, S. J., Ng, L. G., Stanley, E. R., et al. (2010) · Science · doi:10.1126/science.1194637 · Cited by 5,175
Querfurth, H. W., & LaFerla, F. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0909142 · Cited by 4,569
Jack, C. R., Knopman, D. S., Jagust, W. J., Petersen, R. C., Weiner, M. W., Aisen, P. S., Shaw, L. M., Vemuri, P., Wiste, H. J., Weigand, S. D., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70291-0 · Cited by 4,396
Synaptic Pruning by Microglia Is Necessary for Normal Brain Development
Paolicelli, R. C., Bolasco, G., Pagani, F., Maggi, L., Scianni, M., Panzanelli, P., Giustetto, M., Ferreira, T. A., Guiducci, E., Dumas, L., et al. (2011) · Science · doi:10.1126/science.1202529 · Cited by 4,244
Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210
Motor Neuron Degeneration in Mice that Express a Human Cu,Zn Superoxide Dismutase Mutation
Gurney, M. E., Pu, H., Chiu, A. Y., Dal Canto, M. C., Polchow, C. Y., Alexander, D. D., Caliendo, J., Hentati, A., Kwon, Y. W., Deng, H.-X., et al. (1994) · Science · doi:10.1126/science.8209258 · Cited by 4,143
Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner
Schafer, D. P., Lehrman, E. K., Kautzman, A. G., Koyama, R., Mardinly, A. R., Yamasaki, R., Ransohoff, R. M., Greenberg, M. E., Barres, B. A., & Stevens, B. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.026 · Cited by 4,089
ATP mediates rapid microglial response to local brain injury in vivo
Davalos, D., Grutzendler, J., Yang, G., Kim, J. V., Zuo, Y., Jung, S., Littman, D. R., Dustin, M. L., & Gan, W.-B. (2005) · Nature Neuroscience · doi:10.1038/nn1472 · Cited by 3,913
Harold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M. L., Pahwa, J. S., Moskvina, V., Dowzell, K., Williams, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.440 · Cited by 3,326
Mangiarini, L., Sathasivam, K., Seller, M., Cozens, B., Harper, A., Hetherington, C., Lawton, M., Trottier, Y., Lehrach, H., Davies, S. W., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81369-0 · Cited by 3,073
Cited by
Items 901–1,000 of 1,004
Perani, D., Iaccarino, L., Jacobs, A. H., IMBI Brain Imaging Working Group, Lammertsma, A. A., Nordberg, A. K., Windhorst, A. D., Gerhard, A., Winkeler, A., Jacobs, A. H., et al. (2019) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2019.02.004 · Cited by 13
“Additionally, microglia are known to show complex and dynamic types of activation, which can be both beneficial or detrimental [26].”
BackgroundMenezes, R., Foito, A., Jardim, C., Costa, I., Garcia, G., Rosado-Ramos, R., Freitag, S., Alexander, C. J., Outeiro, T. F., Stewart, D., et al. (2020) · Antioxidants · doi:10.3390/antiox9090789 · Cited by 14
“Chronic activation of immune responses is a common link between neurodegeneration and cancer [44].”
BackgroundEditorial: The role of exosomes in neuroinflammation and neurodegeneration
Wang, Y., & Xia, X. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.1109885 · Cited by 11
“Recent studies have unveiled the significant contribution of exosomes to neuroinflammation and neurodegeneration in acute brain damage such as stroke and chronic neurodegenerative diseases like Alzheimer’s disease (AD) (Heneka et al., 2014; Dugger and Dickson, 2017; Xia et al., 2019, 2022).”
BackgroundKatsumoto, A., Kokiko‐Cochran, O. N., Bemiller, S. M., Xu, G., Ransohoff, R. M., & Lamb, B. T. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.978423 · Cited by 12
“Cytokines, chemokines, and molecular mediators are released within hours of a TBI (1, 2), which leads to microglia and astrocytes’ activation and the recruitment of peripheral immune cells.”
BackgroundLiu, J., Zhang, X., Xu, Y., & Zhang, S. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03557-8 · Cited by 11
“The activation of microglia after ischemia involves several stereotypical events including proliferation and morphological transformation [8, 47, 48].”
Mechanistic Approach to Immunity and Immunotherapy of Alzheimer’s Disease: A Review
Islam, M. R., Rabbi, M. A., Hossain, T., Sultana, S., & Uddin, S. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00360 · Cited by 16
Sun, Q., Fan, J., Zhao, L., Qu, Z., Dong, Y., Wu, Y., & Gu, S. (2025) · Foods · doi:10.3390/foods14060989 · Cited by 14
“LPS LPS was positively correlated with Alistipes , Christensene ‐ laceae_R7_group , Eubacterium , and Parasu tt erella . significantly negatively correlated with Bifidobacterium _torques_group , and Lachnospiraceae_UCG_ LPS was signi fi cantly negatively correlated with Bi fi dobacterium , Ruminococcus_torques_group , a…”
Villacampa, N., Sarlus, H., Martorell, P., Bhalla, K., Castro‐Gomez, S., Vieira-Saecker, A. M. M., Slutzkin, I., Händler, K., Venegas, C., McManus, R. M., et al. (2025) · ASN NEURO · doi:10.1080/17590914.2025.2506406 · Cited by 14
“For reasons unknown, the resolution of acute inflammatory responses fails in neurodegenerative disorders and as a result, the innate immune reaction persists (Heneka et al., 2014).”
Self-citationBeyond amyloid: nanobody-mediated neuroinflammatory therapy for Alzheimer’s disease
Amniouel, S., Suh, J., Zheng, W. H., & Zhang, Q. (2025) · Translational Neurodegeneration · doi:10.1186/s40035-025-00513-5 · Cited by 11
Neuropharmacologic Approaches to Restore the Brain’s Microenvironment
Li, W., Tong, H.-I., Gorantla, S., Poluektova, L. Y., Gendelman, H. E., & Lu, Y. (2016) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-016-9686-5 · Cited by 12
“Such changes in phenotype can affect the brain's microenvironment by producing a proinflammatory milieu that speeds neuronal injury and ongoing disease pathogenesis (Heneka et al. 2014).”
Acero, G., Catorce, M. N., González-Mendoza, R., Meraz-Rodríguez, M. A., Hernández-Zimbrón, L. F., González-Salinas, R., & Gevorkian, G. (2017) · Inflammopharmacology · doi:10.1007/s10787-017-0355-y · Cited by 12
“…neurodegenerative diseases such as Alzheimer’s disease (AD), Parkinson’s disease (PD), frontotemporal dementia, amyotrophic lateral sclerosis and multiple sclerosis (Eikelenboom et al. 2010; Heneka et al. 2014; Pasqualetti et al. 2015; Calsolaro and Edison 2016; Ransohoff 2016; Santos et al. 2016).”
BackgroundMannini, B., Vecchi, G., Labrador‐Garrido, A., Fabre, B., Fani, G., Franco, J. M., Lilley, K. S., Pozo, D., Vendruscolo, M., Chiti, F., et al. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00088 · Cited by 10
Genetic analysis of TRIM family genes for early-onset Parkinson's disease in Chinese population
Li, C., Ou, R., Hou, Y., Chen, Y., Gu, X., Wei, Q., Cao, B., Zhang, L., Liu, K., Chen, X., et al. (2021) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2021.08.005 · Cited by 12
The endoplasmic reticulum participated in drug metabolic toxicity
Huang, Q., Chen, Y., Zhang, Z., Xue, Z., Hua, Z., Luo, X., Yang, L., Lu, C. C., Lü, A., & Liu, Y. (2022) · Cell Biology and Toxicology · doi:10.1007/s10565-021-09689-8 · Cited by 9
“Other Than NLRP3” Inflammasomes: Multiple Roles in Brain Disease
Chiarini, A., Armato, U., Gui, L., & Prà, I. D. (2022) · The Neuroscientist · doi:10.1177/10738584221106114 · Cited by 11
Barateau, L., Krache, A., Costa, A. D. S., Lecendreux, M., Debs, R., Chenini, S., Arlicot, N., Vourc’h, P., Evangelista, E., Alonso, M., et al. (2024) · Neurology · doi:10.1212/wnl.0000000000209326 · Cited by 11
“30 Until now, no PET tracer can distinguish between di ff erent microglial subtypes or capture the transition between these di ff erent states.”
Alves, C. J., Maximino, J. R., & Chadi, G. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00332 · Cited by 12
“…role of RIG-I-like receptor gene products in those mechanisms underlying glial cell activation, misfolded proteins/aberrantly localized nucleic acids andmitochondrion signaling-induced autophagy remain unclear (Kawai and Akira, 2008; Tal and Iwasaki, 2009; Heneka et al., 2014; Ying et al., 2015).”
BackgroundPark, J., Kim, J., Jang, B., Im, S., Song, D., & Bae, J. (2015) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2015.12.014 · Cited by 10
Nutritional and Nanotechnological Modulators of Microglia
Maysinger, D., & Zhang, I. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00270 · Cited by 11
Relevance of raised cerebrospinal fluid monocyte levels in patients with frontotemporal dementia
Pawlowski, M., Lueg, G., Groß, C. C., Johnen, A., Krämer, J., Weckesser, M., Wiendl, H., Meuth, S. G., & Duning, T. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.09.032 · Cited by 12
“Interestingly, ample evidence now points to a strong contribution of the innate immune system in both onset and progression of ALS (Butovsky et al., 2012; Heneka et al., 2014; Zondler et al., 2016).”
BackgroundResultInfluentialGene Dysfunction Mediates Immune Response to Dopaminergic Degeneration in Parkinson’s Disease
Jiao, Z., Zhang, W., Chen, C., Zhu, X., Chen, X., Zhou, M., Peng, G., Liu, H., Qiu, J., Lin, Y., et al. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00373 · Cited by 10
Lameth, J., Arnaud‐Cormos, D., Lévêque, P., Boillée, S., Edeline, J., & Mallat, M. (2020) · Neurotoxicity Research · doi:10.1007/s12640-020-00191-3 · Cited by 10
Wickstead, E. S., Irving, M. A., Getting, S. J., & McArthur, S. (2021) · FEBS Journal · doi:10.1111/febs.15861 · Cited by 11
Inhibition of caspase-1 ameliorates tauopathy and rescues cognitive impairment in SAMP8 mice
Tan, M.-S., Liu, Y., Hu, H., Tan, C.-C., & Tan, L. (2022) · Metabolic Brain Disease · doi:10.1007/s11011-022-00914-9 · Cited by 10
“Increasing evidences indicate that chronic neuroinflammation has neurotoxicity and adverse effects on brain functions, which plays a role in the initiation and progression of age-related neurodegenerative diseases (Heneka et al. 2014).”
BackgroundRejecting the Alzheimer's disease vaccine development for the wrong reasons
Marciani, D. J. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.10.012 · Cited by 10
Microglia: You’ll Never Walk Alone!
Villacampa, N., & Heneka, M. T. (2018) · Immunity · doi:10.1016/j.immuni.2018.02.009 · Cited by 11
Self-citationProstate cancer: risk categories and role of hormones and radiotherapy.
Lukka, H. R. (2002) · PubMed · Cited by 10
López‐González, I., Cordomí, C. T., & Ferrer, I. (2017) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlw117 · Cited by 10
Sun, Q., Fan, J., Zhao, L., Qu, Z., Dong, Y., Wu, Y., & Gu, S. (2025) · doi:10.20944/preprints202502.1825.v1 · Cited by 10
Furube, E., Ohgidani, M., & Yoshida, S. (2023) · Neurochemical Research · doi:10.1007/s11064-023-03929-5 · Cited by 11
“Autopsied brains from patients with neurodegenerative diseases showed marked astrogliosis, microglial activation, and high levels of proinflammatory cytokines [3].”
BackgroundVujosevic, S., Limoli, C., & Kozak, I. (2024) · Eye · doi:10.1038/s41433-024-03341-5 · Cited by 10
“…in this process are activated microglia, the resident macrophages within the CNS that comprise around 10–15% of all glial cells, and astrocytes [128], which secrete numerous proinflammatory cytokines, including tumour necrosis factor-alpha (TNF-α), interleukin-1β (IL-1β), and interleukin-6…”
Inosine exerts dopaminergic neuroprotective effects via mitigation of NLRP3 inflammasome activation
Khanal, S., Shin, E., Yoo, C. J., Kim, J., & Choi, D. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.110278 · Cited by 12
Lemoine, M. (2025) · Cambridge University Press eBooks · doi:10.1017/9781009370394 · Cited by 9
Rodríguez-López, A., Esteban, D., Domínguez‐Romero, A. N., & Gevorkian, G. (2025) · Experimental Neurology · doi:10.1016/j.expneurol.2025.115189 · Cited by 9
Ruiz, V. Y., Calderon, T. M., León‐Rivera, R., Chilunda, V., Zhang, J., & Berman, J. W. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1475480 · Cited by 10
Wang, S., Bao, Y., Wang, L., Xie, X., & Lu, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1596806 · Cited by 12
Bidirectional Interplay Between Microglia and Mast Cells
Lakatos, S., & Rosta, J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157556 · Cited by 15
“However, this binary concept of microglia classification (M1/M2) does not cover the entire spectrum of microglial activation states; it can be used to distinguish between neuroprotective and neurotoxic microglial function in the pathobiology of CNS disorders.”
Expression of intron-containing HIV-1 RNA induces NLRP1 inflammasome activation in myeloid cells
Jalloh, S., Hughes, I. A., Akiyama, H., Gojanovich, A. D., Quiñones-Molina, A. A., Yang, M., Henderson, A. J., Mostoslavsky, G., & Gummuluru, S. (2025) · PLoS Biology · doi:10.1371/journal.pbio.3003320 · Cited by 10
When sleep fails, brain clearance suffers: the role of glymphatic impairment in clinical neurology
la Herrán-Arita, A. K. D. (2025) · Acta Neurologica Belgica · doi:10.1007/s13760-025-02959-w · Cited by 17
“1 A) [ 14–17].”
Cell Biology of Parkin: Clues to the Development of New Therapeutics for Parkinson’s Disease
Patel, J., Panicker, N., Dawson, V. L., & Dawson, T. M. (2022) · CNS Drugs · doi:10.1007/s40263-022-00973-7 · Cited by 9
“Therefore, pathologic mechanisms downstream of parkin inactivation may synergize with other molecular effectors of synucleinopathy in promoting cellular dysfunction and death in sporadic PD [12, 106, 208].”
BackgroundShi, Y., Fang, Y., Shen, P. F., Liu, H., Xu, L., Wang, L., & Yang, M. (2023) · Brain and Behavior · doi:10.1002/brb3.2980 · Cited by 8
“Furthermore, the NLRP3 inflammasomes contribute to the microglia-mediated neuroinflammation (Heneka et al., 2014).”
BackgroundAmyloid Beta Peptides Lead to Mast Cell Activation in a Novel 3D Hydrogel Model
Liu, J., Liu, S., Zeng, L., & Tsilioni, I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512002 · Cited by 12
Shu, S., Jiang, M., Deng, X., Yue, W., Cao, X., Zhang, K., Wang, Z., He, H., Cui, J., Wang, Q., et al. (2023) · Aging Cell · doi:10.1111/acel.13947 · Cited by 9
“…functions decrease with age, leading to immunosenescence (DeVeale et al., 2004 ; Scheiblich et al., 2020 ); on the other hand, chronic elevation of the innate immunity is associated with age-related human diseases, especially neurodegenerative disorders (Heneka et al., 2014; Labzin et al., 2018 ).”
BackgroundA Critical Analysis of the FDA’s Omics-Driven Pharmacodynamic Biomarkers to Establish Biosimilarity
Niazi, S. K. (2023) · Pharmaceuticals · doi:10.3390/ph16111556 · Cited by 13
Takase, H., Hamanaka, G., Hoshino, T., Ohtomo, R., Guo, S., Mandeville, E. T., Lo, E. H., & Arai, K. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-231049 · Cited by 9
“Accumulating evidence suggests that in the aging brain and in AD, microglia-mediated chronic neuroinflammation might be the central mechanism [41].”
Salmina, A. B., Komleva, Y. K., Kuvacheva, N. V., Lopatina, O. L., Пожиленкова, Е. А., Gorina, Y. V., Gasymly, E. D., Panina, Y. A., Morgun, A. V., & Malinovskaya, N. A. (2015) · Annals of the Russian academy of medical sciences · doi:10.15690/vramn.v70i1.1227 · Cited by 12
“Помимо резидентных клеток миелоидной природы — микроглии, традиционно рассматриваемой в качестве ключевого участника процесса нейровоспаления [8], все больше внимания уделяют роли астроцитов как эффекторных клеток в очаге воспаления в ткани головного мозга.”
CD200 is up-regulated in R6/1 transgenic mouse model of Huntington's disease
Comella-Bolla, A., Valente, T., Miguez, A., Brito, V., Ginés, S., Solà, C., Straccia, M., & Canals, J. M. (2019) · PLoS ONE · doi:10.1371/journal.pone.0224901 · Cited by 11
“In this view, neurodegenerative diseases are depend on the same innate immune pathway, chronically activating microglia through CD200 downregulation [50].”
BackgroundIntracellular and Mitochondrial Reactive Oxygen Species Measurement in Primary Cultured Neurons
Baek, S. H., Cho, Y., Lee, J., Choi, B. Y., Choi, Y., Park, J. K., Kim, H., Sul, J., Kim, E., Park, J. H., et al. (2018) · BIO-PROTOCOL · doi:10.21769/bioprotoc.2466 · Cited by 10
Yu, Q., Liu, M., Dai, W., Xiong, Y., Mu, X., Xia, M., Li, Y., Ma, S., Su, Y., Wu, J., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.974905 · Cited by 8
“Moreover, the NLRP3 inflammasome plays an important role in these processes and can be a therapeutic target (Heneka et al., 2014).”
BackgroundKang, S., Kim, C., Aiken, J. M., Yoo, H. S., & McKenzie, D. I. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0495-5 · Cited by 8
Shan, Y., Gao, Y., Zhang, L., Ma, L., Shi, Y., & Liu, X. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.11.050 · Cited by 10
Chen, Y., & Xu, R. (2019) · BMC Medical Genomics · doi:10.1186/s12920-018-0459-2 · Cited by 9
Kaur, S., & Aballay, A. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107662 · Cited by 8
“The role of activated microglia in disease progression in various degenerative neurological conditions (Heneka et al., 2014) points toward the involvement of cell-non-autonomous factors.”
BackgroundLameth, J., Gervais, A., Colin, C., Lévêque, P., Jay, T. M., Edeline, J., & Mallat, M. (2017) · Neurotoxicity Research · doi:10.1007/s12640-017-9774-1 · Cited by 9
Huang, T., Huang, J., Shang, Y., & Jian, X. (2023) · ALPHA PSYCHIATRY · doi:10.5152/alphapsychiatry.2023.231281 · Cited by 10
“21,22 Patients with major depressive disorder (MDD) and chronic stress models yield similar outcomes.”
BackgroundSiddique, A. H. H., & Kale, P. P. (2023) · Revue Neurologique · doi:10.1016/j.neurol.2023.08.011 · Cited by 11
Amyotrophic Lateral Sclerosis Mechanism: Insights from the Caenorhabditis elegans Models
Chen, L., Zhang, S., Liu, S., & Gao, S. (2024) · Cells · doi:10.3390/cells13010099 · Cited by 11
“Notably, mutated ALS-associated proteins have been found to activate an innate immune response in C. elegans [81–83].”
BackgroundThe Relevance of Astrocytic Cell Culture Models for Neuroinflammation in Neurodegeneration Research
Preato, A. M., Pinheiro, E. D. S., Rosenstock, T. R., & Glezer, I. (2024) · Neuroglia · doi:10.3390/neuroglia5010003 · Cited by 10
Hao, M., Chu, J., Zhang, T., Yin, T., Gu, Y., Liang, W., Ji, W., Zhuang, J., Liu, Y., Gao, J., et al. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-23-01736 · Cited by 9
“AD: Alzheimer’s disease; BBB: blood– brain barrier; siRNA: small interfering RNA.”
BackgroundInfluentialGuardians under Siege: Exploring Pollution’s Effects on Human Immunity
Drago, G., Aloi, N., Ruggieri, S., Longo, A., Contrino, M. L., Contarino, F. M., Cibella, F., Colombo, P., & Longo, V. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147788 · Cited by 12
“…in non-communicable diseases that are characterized by a chronic low level of inflammation, including autoimmune [13] and neurodegenerative conditions [14], cardiovascular diseases [15], cancer [16], diabetes mellitus, and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) [17,18].”
BackgroundInflammasomes in Alzheimer’s Progression: Nrf2 as a Preventive Target
López-Hernández, R., de la Torre-Álamo, M. M., García-Bueno, B., Baroja‐Mazo, A., Fenoy, F. J., & Cuevas, S. (2025) · Antioxidants · doi:10.3390/antiox14020121 · Cited by 11
Meng, H., Chen, X., He, L., Chunyu, H., Zhou, Q., Wang, J., Qu, Q., Hai, W., Zhang, Y., Li, B., et al. (2025) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-025-07305-z · Cited by 8
“Microglia activation is a pathological hallmark of neuroinflammation [10].”
Wu, L., Lin, T., Zhang, Z., Peng, D., Xiao, S., Liang, J., Yu, H., Wáng, Y., Huang, F., & Yan, H. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.120346 · Cited by 11
CD33 and SIGLECL1 Immunoglobulin Superfamily Involved in Dementia
Rendina, A., Drongitis, D., Donizetti, A., Fucci, L., Milan, G., Tripodi, F. S., Giustezza, F., Postiglione, A., Pappatà, S., Ferrari, R., et al. (2020) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlaa055 · Cited by 10
“However, it is likely that the CD33m isoform protective properties are linked to a loss of function (29).”
BackgroundLee, J., Kong, E., Hong, S., Moon, J., & Kim, P. (2020) · Biomedical Optics Express · doi:10.1364/boe.393690 · Cited by 8
Panaxytriol Inhibits Lipopolysaccharide-Induced Microglia Activation in Brain Inflammation in Vivo
Hiramatsu, G., Matsuda, K., Uta, D., Mihara, K., & Kume, T. (2021) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b21-00288 · Cited by 8
Korshoj, L. E., Shi, W., Duan, B., & Kielian, T. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.670931 · Cited by 8
“Activation occurs through the recognition of pathogenassociated molecular patterns (PAMPs) by a range of pattern recognition receptors (PRRs), the most well studied being the Toll-like receptor (TLR) family (44, 45).”
BackgroundCores, Á., Michalska, P., Pérez, J. M., Crisman, E., Gómez, C., Villacampa, M., Menéndez, J. C., & Leon, R. M. (2022) · Antioxidants · doi:10.3390/antiox11010112 · Cited by 8
“For example, it is known that amyloid-β (Aβ) aggregates present in AD brains activate the toll-like receptors (TLRs) on glial cells, hence increasing the pro-inflammatory mediators and toxicity [17]; moreover, OS impairs the response of redox sensitive transcription factors, such as NF-KB and NRF2, leading to a chroni…”
BackgroundExposure to a real traffic environment impairs brain cognition in aged mice
Xu, C., Zhang, J., Zhou, Q., Wang, J., Liu, C., Tian, Y., Huang, D., Ye, H., & Jin, Y. (2022) · Environmental Research · doi:10.1016/j.envres.2022.114181 · Cited by 10
The Adult Neurogenesis Theory of Alzheimer’s Disease
Abbate, C. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-221279 · Cited by 12
“postmortem [78, 79] and “in vivo” clinical studies”
BackgroundWu, J., Chen, J., Ge, Y., Huang, N., & Luo, Y. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e29424 · Cited by 11
Hu, Y., Yan, F., Ying, L., & Xu, D. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-5987-2_3 · Cited by 8
Zhang, Y., Liu, D., Yao, X., Wen, J., Wang, Y., & Zhang, Y. (2022) · Neuroscience Letters · doi:10.1016/j.neulet.2022.136770 · Cited by 9
Cancer and Vascular Comorbidity Effects on Dementia Risk and Neuropathology in the Oldest-Old
Lachner, C., Day, G. S., Camsari, G. B., Kouri, N., Ertekin‐Taner, N., Boeve, B. F., Labuzan, S. A., Lucas, J. A., Thompson, E. A., Siddiqui, H., et al. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220440 · Cited by 8
“The effects of aging on the immune system, innate immune activation, as well as neuroinflammation were also implicated in neurodegeneration [41, 42].”
BackgroundKomic, A., Quinones, P. M., McCarthy, C. G., Webb, R. C., & Wenceslau, C. F. (2018) · Clinical Science · doi:10.1042/cs20180368 · Cited by 8
“Chronic activation of innate immune system signaling pathways and sustained exposure of neurons to pro-inflammatory mediators has been shown to cause cellular dysfunction and contribute to cell death in neurodegenerative disorders (28).”
Imaging of neuroinflammation: TSPO and beyond
Varrone, A., & Lammertsma, A. A. (2015) · Clinical and Translational Imaging · doi:10.1007/s40336-015-0149-4 · Cited by 8
Yoon, S., Boonpraman, N., Kim, C. Y., Moon, J., & Yi, S. S. (2023) · BMB Reports · doi:10.5483/bmbrep.2022-0208 · Cited by 10
Hernández, E. R., Hernández-Zimbrón, L. F., Pérez, E. S., Sánchez‐Salgado, J. L., Morales, M. A. P., & Zenteno, E. (2024) · Neuropeptides · doi:10.1016/j.npep.2024.102426 · Cited by 11
“In concordance with several reports, the A β 25 – 35 peptide promotes a release of inflammatory mediators that have a neurotoxic effect, contributing to disease progression and severity in the neuro-degeneration (Bronzuoli et al., 2016; Diaz et al., 2012; Heneka et al., 2014).”
ResultZhang, Q., Wang, Y., Zhao, L., Su, G., Ding, W., Zheng, L. P., & Zhao, M. (2024) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.4c03029 · Cited by 7
Repositioning anthelmintics for the treatment of inflammatory-based pathological conditions
Rodrigues, D. C. D. N., Porto, J. C. S., dos Santos, I. L., Filho, J. I. A. B., & Ferreira, P. M. P. (2024) · Inflammopharmacology · doi:10.1007/s10787-024-01605-w · Cited by 9
“…is the pathogenic basis of different chronic diseases, such as cardiovascular, gastrointestinal, neurodegenerative, kidney diseases, and cancers (Heneka et al. 2014; Miller and Raison 2016; Gistera and Hansson 2017; Ferrucci and Fab-bri 2018; Taniguchi and Karin 2018; Ribaldone et al. 2019).”
Alonaizan, R., Alotaibi, W. K., Alsulami, A., Alkhulaifi, F. M., & Alomar, S. Y. (2024) · Immunological Investigations · doi:10.1080/08820139.2024.2440006 · Cited by 10
“Microglia is an immune cell that makes up 5–12% of CNS cells and is distributed throughout the brain (Heneka et al., 2014).”
Molinsky, R. L., Shah, A. M., yuzefpolskaya, M., Yu, B., Misialek, J. R., Bohn, B., Vock, D. M., MacLehose, R. F., Borlaug, B. A., Colombo, P. C., et al. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.123.033877 · Cited by 9
“43 48 Notable examples of low-grade asymptomatic inflammation causing end-organ damage include obesity 49 and aging, as evidenced by an increase in circulating levels of TNF-α (tumor necrosis factor alpha) and IL-6 (interleukin-6).”
Proteomic meta-analysis unveils new frontiers for biomarkers research in pancreatic carcinoma
Marco, F. D., Cufaro, M. C., Damiani, V., Dufrusine, B., Pizzinato, E., Ferdinando, F. D., Sala, G., Lattanzio, R., Dainese, E., Federici, L., et al. (2025) · Oncogenesis · doi:10.1038/s41389-025-00547-4 · Cited by 7
“In this context, it would, therefore, be interesting to further research on tissue biomarkers in PC.”
Hao, K., Chen, F., Xu, S., Xiong, Y., Xu, R., Huang, H., Shu, C., Lv, Y., Wang, G., & Wang, H. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03318-2 · Cited by 11
“The NAD + /SIRT3 axis might be a promising therapeutic target for addressing cognitive de fi cits associated with schizophrenia.”
Zhu, Q., Song, Y., Qian, Y., Zhang, R., Xue, J., & Hou, Y. (2025) · Ageing and Neurodegenerative Diseases · doi:10.20517/and.2025.25 · Cited by 10
Ang, S., Zhang, X., Hong, J., Xue, K., Li, J., Du, X., Gao, Y., Wang, X., Li, X., Chen, B., et al. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03788-4 · Cited by 10
Rueda-Gensini, L., Serna, J. A., Bolaños, N. I., Rodríguez, J., Cruz, J. C., & Muñoz-Camargo, C. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.905347 · Cited by 8
Carvalho, D. B., Díaz‐Amarilla, P., Dapueto, R., Santi, M. D., Duarte, P., Savio, E., Engler, H., Abin‐Carriquiry, J. A., & Arredondo, F. (2023) · Journal of Molecular Neuroscience · doi:10.1007/s12031-023-02105-2 · Cited by 7
“…functions that help preserve neuronal tissue in multiple disorders, even though in contexts like excessive neuro-inflammation it can also be associated with loss of astrocyte homeostatic functions or even gain of detrimental functions (Glass et al. 2010; Heneka et al. 2014; Sofroniew 2020).”
BackgroundDing, X., Chen, Y., Zhang, X., Duan, Y., Yuan, G., & Liu, C. (2024) · Neuropeptides · doi:10.1016/j.npep.2024.102457 · Cited by 8
Sharma, S., Gilberto, V. S., Rask, J. C., Chatterjee, A., & Nagpal, P. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00160 · Cited by 11
Designed Cell-Penetrating Peptide Constructs for Inhibition of Pathogenic Protein Self-Assembly
Kalmouni, M., Oh, Y., Alata, W., & Magzoub, M. M. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16111443 · Cited by 7
“The presence of inflammation at sites of amyloid deposition is another pathological characteristic of these diseases, as tissue damage caused by amyloid fibrils elicits an immune response, producing proinflammatory cytokines [6,7].”
Endocrine influence on neuroinflammation: the use of reporter systems
Rizzi, N., Villa, A. M., Benedusi, V., Brunialti, E., Cesari, N., Ciana, P., & Maggi, A. C. (2017) · Journal of Neuroendocrinology · doi:10.1111/jne.12496 · Cited by 7
Salvianolate reduces neuronal apoptosis by suppressing OGD-induced microglial activation
Luan, P., Ding, X., Xu, J., Jiang, L., Xu, Y., Zhu, Y., Li, R., & Zhang, J. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118393 · Cited by 7
Roles of microglial membranes in Alzheimer's disease
Shin, J., & Lee, J. C. (2020) · Current topics in membranes · doi:10.1016/bs.ctm.2020.08.007 · Cited by 7
Morse, S. V., Boltersdorf, T., Chan, T. G., Gavins, F. N. E., Choi, J. J., & Long, N. J. (2020) · RSC Chemical Biology · doi:10.1039/d0cb00140f · Cited by 8
Timmerman, R., Zuiderwijk-Sick, E. A., Oosterhof, N., Jong, A. E. J. '., Veth, J., Burm, S. M., van Ham, T. J., & Bajramovic, J. J. (2021) · Glia · doi:10.1002/glia.24136 · Cited by 8
Dietary restriction ameliorates TBI-induced phenotypes in Drosophila melanogaster
Delventhal, R., Wooder, E. R., Basturk, M. K., Sattar, M., Lai, J., Bolton, D., Muthukumar, G., Ulgherait, M., & Shirasu‐Hiza, M. (2022) · Scientific Reports · doi:10.1038/s41598-022-13128-x · Cited by 8
Huang, L., Gong, L.-Q., Huo, X.-Y., Lei, L.-R., Zhang, Q., Hu, Y.-J., Kuang, Q.-X., Gui, Y., Dai, Y., Gu, Y., et al. (2022) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2022116 · Cited by 18
“Neuroinflammation generally refers to the immune response of immune cells within the central nervous system (CNS) that can be caused by trauma, ischemia, infection, toxins, autoimmunity and so on [1].”
BackgroundInfluentialPreclinical Evidence-based Neuroprotective Potential of Silibinin
Singh, N. K., & Bhushan, B. (2023) · Current Drug Research Reviews · doi:10.2174/2589977515666230327154800 · Cited by 9
Targeting phosphodiesterase 4 as a potential therapy for Parkinson’s disease: a review
Nongthombam, P. D., & Haobam, R. (2024) · Molecular Biology Reports · doi:10.1007/s11033-024-09484-8 · Cited by 7
“It is mainly related to the etiology of the development and progression of many neurodegenerative disorders [ 66 ].”
Metadata
- Authors
- Heneka, M. T., Kummer, M. P., & Latz, E.
- Affiliations
- University of Bonn (DE)
- Corresponding author
- Heneka, Michael T.
- Venue
- Nature Reviews Immunology
- Published
- 2014-06-25
- Volume
- 14
- Issue
- 7
- Pages
- 463-477
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W1986611577
- Cited by
- 1,437
- References
- 171
- Citations by year
- 2026: 109 · 2025: 137 · 2024: 118 · 2023: 104 · 2022: 125 · 2021: 143 · 2020: 158 · 2019: 117 · 2018: 116 · 2017: 106 · 2016: 96 · 2015: 97 · 2014: 9
- FWCI
- 8.30
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- Open Repository and Bibliography (University of Luxembourg) (submittedVersion)
- DZNE Pub (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- innate immunity, neurodegenerative diseases, neuroinflammation, microglia, NLRP3 inflammasome, NOD-like receptors, misfolded proteins, pro-inflammatory mediators, neuronal dysfunction, neuronal cell death, neurodegeneration therapy
- MeSH terms
- NLR Family, Pyrin Domain-Containing 3 Protein, Brain, Carrier Proteins, Humans, Immunity, Innate, Inflammation, Signal Transduction, Cytokines, Amyloid beta-Peptides, Reactive Oxygen Species, Protein Folding, Microglia, Oxidative Stress, Neurodegenerative Diseases, Reactive Nitrogen Species, Receptors, Pattern Recognition, Inflammasomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.